Home Table of Contents

§ 15-851. Prior authorization requirement for drugs to treat opioid use disorders prohibited

West's Annotated Code of MarylandInsuranceEffective: May 25, 2017

West's Annotated Code of Maryland
Insurance (Refs & Annos)
Title 15. Health Insurance
Subtitle 8. Required Health Insurance Benefits (Refs & Annos)
Effective: May 25, 2017
MD Code, Insurance, § 15-851
§ 15-851. Prior authorization requirement for drugs to treat opioid use disorders prohibited
Currentness
Scope of section
(a)(1) This section applies to:
(i) insurers and nonprofit health service plans that provide coverage for substance use disorder benefits or prescription drugs under individual, group, or blanket health insurance policies or contracts that are issued or delivered in the State; and
(ii) health maintenance organizations that provide coverage for substance use disorder benefits or prescription drugs under individual or group contracts that are issued or delivered in the State.
(2) An insurer, a nonprofit health service plan, or a health maintenance organization that provides coverage for substance use disorder benefits under the medical benefit or for prescription drugs through a pharmacy benefits manager is subject to the requirements of this section.
Prohibition
(b) An entity subject to this section may not apply a prior authorization requirement for a prescription drug:
(1) when used for treatment of an opioid use disorder; and
(2) that contains methadone, buprenorphine, or naltrexone.

Credits

Added by Acts 2017, c. 581, § 1, eff. May 25, 2017.
MD Code, Insurance, § 15-851, MD INSURANCE § 15-851
Current through legislation effective through July 1, 2024, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document